Axplora Invests €50M in France’s Mourenx Site, Cementing Europe’s Leadership in Peptide Purification

The €50+ million investment will enhance Axplora CDMO’s Mourenx site with state-of-the-art facilities and infrastructure improvements. Axpl...

February 12, 2025 | Wednesday | News
GHIT Fund Announces JPY 2 Billion Investment in New Diagnostics and Drugs for Neglected Tropical Diseases and Malaria

The Global Health Innovative Technology (GHIT) Fund announced a total investment of approximately JPY 2 billion (USD 12.7 million1) in eight...

January 30, 2025 | Thursday | News
AstraZeneca Announces C$820 Million Investment in Ontario, Creating Over 700 High-Skilled Jobs

AstraZeneca, a global pharmaceutical company focused on developing life changing medicines,  announced a C$820 million (US$570m) investment in Canada,...

January 24, 2025 | Friday | News
Disc Medicine Announces Upsized $225.5 Million Public Offering of Common Stock and Pre-Funded Warrants

Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel...

January 23, 2025 | Thursday | News
Beckman Coulter Life Sciences and Indiana University Secure $2.5M Grant to Boost Leukemia and Lymphoma Testing in Kenya

Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, along with the Indiana University School of Medicine, have been a...

January 22, 2025 | Wednesday | News
Ocular Therapeutix Grants Inducement Awards to New Employee Under 2019 Stock Incentive Plan

Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to redefining the retina ex...

January 20, 2025 | Monday | News
Japan-Based Meiji Seika Pharma Invests $20 Million in U.S.-Based MPM BioImpact to Drive Innovations in Virology and Biotech

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo; President and Representative Director: Daikichiro Kobayashi, hereinafter “Meiji”) announce...

January 13, 2025 | Monday | News
etherna Immunotherapies and Dropshot Therapeutics Join Forces to Accelerate RNA-Based Therapeutics Development

etherna immunotherapies NV (“etherna”), a technology platform leader pioneering mRNA and lipid-based nanoparticle (LNP) technologies, announc...

January 10, 2025 | Friday | News
Innocan Pharma Successfully Completes Non-Brokered Private Placement, Raising $635,444.60 to Advance CBD-Loaded Liposome Platform

Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its previously announced no...

January 01, 2025 | Wednesday | News
Novo Nordisk Commits 8.5 Billion DKK to Transformative Production Facility in Odense, Strengthening Denmark and Europe’s Biopharma Landscape

Novo Nordisk announced plans to invest 8.5 billion Danish kroner to establish a completely new production facility in Odense, Denmark. The investment mar...

December 16, 2024 | Monday | News
R-Bridge Healthcare Fund Closes US$50 Million Growth Financing for Human Investments Ltd. to Expand Motiva® Brand in Asia

R-Bridge Healthcare Fund ("R-Bridge"), an affiliate of CBC Group, Asia's largest healthcare-dedicated asset management firm, today announced...

December 13, 2024 | Friday | News
Hovione Expands Global Footprint with Major Investments in U.S. and Europe

    Hovione, the specialist integrated CDMO and the leader in spray drying and particle engineering, just completed significant expansions in...

November 27, 2024 | Wednesday | News
BioNTech Acquires Biotheus to Strengthen Oncology Pipeline with Bispecific Antibody Asset BNT327/PM8002

BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Biotheus (“Biotheus”) announced the signing of a definitive agreement for...

November 14, 2024 | Thursday | News
TrakCel's OCELLOS Platform Chosen to Support Five Key Cell Therapy Products in 2024, Streamlining CGT Supply Chain Management

TrakCel, a provider of integrated cell and gene therapy (CGT) orchestration solutions for the precise management, control and tracking of CGTs has announce...

November 13, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close